XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net loss $ (173,744) $ (407,034)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and intangible asset amortization 944,080 966,893
Amortization of deferred subscriber acquisition costs 58,830 45,416
Amortization of deferred subscriber acquisition revenue (77,888) (59,017)
Share-based compensation expense 29,606 48,327
Deferred income taxes (62,596) (115,422)
Provision for losses on receivables and inventory 18,568 77,876
Loss on extinguishment of debt 156 65,843
Intangible asset impairments 17,883 0
Unrealized (gain) loss on interest rate swap contracts (92,057) 97,900
Other non-cash items, net 70,800 78,101
Changes in operating assets and liabilities, net of the effects of acquisitions:    
Deferred subscriber acquisition costs (147,593) (94,865)
Deferred subscriber acquisition revenue 129,854 70,039
Other, net 69,761 (145,050)
Net cash provided by operating activities 785,660 629,007
Cash flows from investing activities:    
Dealer generated customer accounts and bulk account purchases (339,655) (144,463)
Subscriber system asset expenditures (339,250) (137,231)
Purchases of property and equipment (83,991) (76,245)
Acquisition of businesses, net of cash acquired (16,411) (179,372)
Other investing, net 2,145 1,737
Net cash used in investing activities (777,162) (535,574)
Cash flows from financing activities:    
Proceeds from long-term borrowings 10,729 1,640,000
Proceeds from receivables facility 71,276 19,852
Repayment of long-term borrowings, including call premiums (32,068) (1,673,607)
Repayment of receivables facility (16,693) (423)
Dividends on common stock (58,049) (53,323)
Deferred financing costs (174) (15,616)
Other financing, net (34,761) (12,910)
Net cash used in financing activities (59,740) (96,027)
Net decrease in cash and cash equivalents and restricted cash and restricted cash equivalents (51,242) (2,594)
Cash and cash equivalents and restricted cash and restricted cash equivalents at beginning of period 207,747 48,736
Cash and cash equivalents and restricted cash and restricted cash equivalents at end of period 156,505 46,142
Supplemental schedule of non-cash investing and financing activities:    
Issuance of shares for acquisition of business $ 0 $ 113,841